Australia to India: Betadine Import Trade Route

The Australia to India Betadine corridor is one of India's established pharmaceutical import routes from Australia, with 1 shipments documented worth a combined $2 USD. The route is dominated by ADIRA MEDICA PTY LTD , which alone accounts for roughly 100% of all import value, reflecting the consolidated nature of Australia's betadine export sector.

Across 1 active Australia suppliers, the average shipment value stands at $2 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with betadine's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 19.4%, placing it at rank #14 among India's top betadine import origins globally.

On the Indian buyer side, key Indian importers include SAI PARENTERAL'S LIMITED . SAI PARENTERAL'S LIMITED is the single largest Indian importer with 1 shipments valued at $2 USD.

India's betadine imports from Australia are driven primarily by a handful of large-scale Australia manufacturers. ADIRA MEDICA PTY LTD with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — Indian buyers benefit from Australia supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ADIRA MEDICA PTY LTD — together account for 100% of total trade value on this route. The average shipment value of $2 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, SAI PARENTERAL'S LIMITED is the largest importer with 1 shipments worth $2 USD — representing 100% of all betadine imports from Australia on this route.